Another putative pathophysiological mechanism that might explain the rise of AVP and copeptin in myocardial ischemia could be based on the rationale that AVP has a modulatory role on the coronary vascular tone, although experimental studies have reported contradictory results [59]. The gene discussed is AVP; the disease is myocardial ischemia.